Error: Could not add to watchlist. X
+ Watchlist

Abraxis BioScience Inc

ABII:US
Acquired
ABII:US was acquired by CELG:US
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.52
Market Cap (USD)
-
Shares Outstanding (m)
40.735
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Abraxis BioScience, Inc. operates as a fully integrated biotechnology company. The Company develops a full spectrum of products used primarily in oncology, infectious diseases, and critical care, including a protein-based nanoparticle chemotherapeutic compound for the treatment of breast cancer.
Address
11755 Wilshire Blvd
Suite 2000
Los Angeles, CA 90025
United States
Phone
1-310-883-1300